Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jade Dinh"'
Autor:
Daniel C. Beachler, Francois-Xavier Lamy, Leo Russo, Devon H. Taylor, Jade Dinh, Ruihua Yin, Aziza Jamal-Allial, Samuel Dychter, Stephan Lanes, Patrice Verpillat
Publikováno v:
Journal of Ovarian Research, Vol 13, Iss 1, Pp 1-13 (2020)
Abstract Background Detailed epidemiologic descriptions of large populations of advanced stage ovarian cancer patients have been lacking to date. This study aimed to describe the patient characteristics, treatment patterns, survival, and incidence ra
Externí odkaz:
https://doaj.org/article/907019ac890a4522a8114737b0fbef6c
Autor:
Ezra Fishman, John Barron, Jade Dinh, W. Schuyler Jones, Amanda Marshall, Rebecca Merkh, Holly Robertson, Kevin Haynes
Publikováno v:
Contemporary Clinical Trials Communications, Vol 12, Iss , Pp 154-160 (2018)
Objective: Validate an algorithm that uses administrative claims data to identify eligible study subjects for the ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) pragmatic clinical trial (PCT). Mater
Externí odkaz:
https://doaj.org/article/cf7eef6af00340448634d942e525f302
Autor:
Catherine B. Johannes, Daniel C. Beachler, J. Bradley Layton, Heather E. Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall-Vila, Phillip R. Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia Gilsenan
Publikováno v:
Drug Safety. 46:157-174
Dapagliflozin is a sodium-glucose cotransporter 2 inhibitor approved to treat type 2 diabetes mellitus (T2DM), among other conditions. When dapagliflozin was approved in Europe for treating T2DM (2012), potential safety concerns regarding its effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9ebfbe422918481ffd13833f3c8960a
https://doi.org/10.1007/s40264-022-01263-3
https://doi.org/10.1007/s40264-022-01263-3
Autor:
Daniel C Beachler, Francois Xavier Lamy, Francesca Kolitsopoulos, Jade Dinh, Anahit Papazian, Aziza Jamal-Allial, Seyed Hamidreza Mahmoudpour, Elisabete Michelon, Patrice Verpillat
Publikováno v:
Future Oncology. 18:2891-2901
Researchers wanted to investigate side effects identified with advanced lung cancer during treatment, particularly immunotherapy. To investigate these side effects, researchers examined health insurance claims records from patients who were diagnosed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46613a9389a457602981b0b784ec674a
https://doi.org/10.2217/fon-2022-0308
https://doi.org/10.2217/fon-2022-0308
Autor:
Francesca Kolitsopoulos, Francois-Xavier Lamy, Frank Xiaoqing Liu, Mo Yang, Xinke Zhang, Aziza Jamal-Allial, Elizabeth T. Masters, Daniel C. Beachler, Jade Dinh
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 28:255-265
BACKGROUND: The treatment landscape for advanced nonsmall cell lung cancer (NSCLC) has evolved from 2015 onward, since the introduction of immune checkpoint inhibitors (ICIs). Considering this shif...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea735eaead62016eea430035de170c4a
https://doi.org/10.18553/jmcp.2021.21216
https://doi.org/10.18553/jmcp.2021.21216
Autor:
Heather E. Danysh, Catherine B. Johannes, Daniel C. Beachler, J. Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall-Vila, Phillip R. Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia Gilsenan
Publikováno v:
Drug safety.
At the time of dapagliflozin's approval in Europe (2012) to treat patients with type 2 diabetes mellitus, concerns regarding acute liver injury and severe complications of urinary tract infection (sUTI) led to two post-authorization safety (PAS) stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::012da253059c17eaa578952965e56089
https://pubmed.ncbi.nlm.nih.gov/36583828
https://pubmed.ncbi.nlm.nih.gov/36583828
Autor:
Judith J. Stephenson, Jade Dinh, David M. Kern, M. Soledad Cepeda, Jie Zhang, Kelsey Hall, Daina B. Esposito
Publikováno v:
Journal of Pain Research. 13:689-701
Background/rationale Little is known about the reasons for visiting multiple doctors/pharmacies, known as doctor/pharmacy shopping, to obtain opioids. Objective To investigate patients' self-reported reasons for doctor/pharmacy shopping and assess wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbc09a4e4e9c1d98a26bf08506f20a89
https://doi.org/10.2147/jpr.s232409
https://doi.org/10.2147/jpr.s232409
Autor:
Cecilia Karlsson, Alicia Gilsenan, Ryan Ziemiecki, Heather Elizabeth Danysh, Catherine Johannes, J. Bradley Layton, Ling Li, Jade Dinh, DC Beachler, Hungta Chen, PR Hunt
Publikováno v:
Diabetes. 70
A noninterventional postauthorization safety study in adult patients with type 2 diabetes compared the incidence of hospitalized diagnoses of acute kidney injury (hAKI) in new users of dapagliflozin and new users of comparator glucose-lowering drugs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0baa2e31df6f19c2c4de9a0d9f0e09e8
https://doi.org/10.2337/db21-14-or
https://doi.org/10.2337/db21-14-or
Autor:
PR Hunt, Catherine Johannes, J. Bradley Layton, Ling Li, DC Beachler, Hungta Chen, Heather Elizabeth Danysh, Jade Dinh, Ryan Ziemiecki, Alicia Gilsenan, Cecilia Karlsson
Publikováno v:
Diabetes. 70
A noninterventional postauthorization safety study of patients with type 2 diabetes compared the incidence of hospitalized acute liver injury (hALI) in new users of dapagliflozin and new users of comparator glucose-lowering drugs (GLDs), matched on y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d42a9bb707e469d14ef8ddebe061695
https://doi.org/10.2337/db21-806-p
https://doi.org/10.2337/db21-806-p
Autor:
J. Bradley Layton, Ling Li, DC Beachler, Hungta Chen, Catherine Johannes, Alicia Gilsenan, Cecilia Karlsson, Heather Elizabeth Danysh, Ryan Ziemiecki, Jade Dinh, PR Hunt
Publikováno v:
Diabetes. 70
A noninterventional postauthorization safety study in patients with type 2 diabetes compared the sex-specific incidence of severe complications of urinary tract infections (sUTI) (pyelonephritis or urosepsis) in new users of dapagliflozin and new use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82cb376cf2dc99658c6c3c60976b13f4
https://doi.org/10.2337/db21-805-p
https://doi.org/10.2337/db21-805-p